Swiss Group for Clinical Cancer Research

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 1965-01-01

Employees: -

Market Cap: -

Website: http://www.sakk.ch/

Clinical Trials

Metronomic Therapy in Metastatic Breast Cancer.

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Biological: Bevacizumab, Cyclophosphamide, Capecitabine
Biological: bevacizumab, Paclitaxel

First Posted Date: 2010-05-26

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 139

Registration Number: NCT01131195

Locations: 🇨🇭
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland
🇨🇭
Spitalzentrum Biel, Biel, Switzerland
🇨🇭
Hirslanden Klinik Aarau, Aarau, Switzerland

and more 20 locations

Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Biological: bevacizumab, erlotinib
Drug: bevacizumab, pemetrexed, cisplatin

First Posted Date: 2010-05-04

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 149

Registration Number: NCT01116219

Locations: 🇨🇭
Saint Claraspital AG, Basel, Switzerland
🇨🇭
Spitalzentrum Biel, Biel, Switzerland
🇨🇭
Kantonsspital Bruderholz, Bruderholz, Switzerland

and more 19 locations

Radiation Therapy and Chemotherapy, With or Without Cetuximab, Followed by Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

Phase 3

Completed

Conditions: Adenocarcinoma of the Gastroesophageal Junction
Esophageal Cancer

Interventions: Biological: cetuximab
Drug: cisplatin
Drug: docetaxel
Procedure: adjuvant therapy
Procedure: neoadjuvant therapy

First Posted Date: 2010-04-21

Last Posted Date: 2020-10-20

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 297

Registration Number: NCT01107639

Locations: 🇨🇭
Hôpital du Valais (RSV)-CHCVs, Sion, Switzerland
🇨🇭
Kantonsspital Winterthur, Winterthur, Switzerland
🇨🇭
City Hospital Triemli, Zurich, Switzerland

and more 54 locations

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: cetuximab
Drug: cisplatin
Drug: docetaxel
Radiation: Radiotherapy
Procedure: Surgery

First Posted Date: 2010-01-29

Last Posted Date: 2022-03-11

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 69

Registration Number: NCT01059188

Locations: 🇨🇭
Regionalspital, Thun, Switzerland
🇨🇭
UniversitaetsSpital Zuerich, Zurich, Switzerland
🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

and more 12 locations

Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: paclitaxel
Drug: vadimezan

First Posted Date: 2010-01-27

Last Posted Date: 2013-04-10

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 17

Registration Number: NCT01057342

Locations: 🇨🇭
Inselspital Bern, Bern, Switzerland
🇨🇭
Spitalzentrum Biel, Biel, Switzerland
🇨🇭
Saint Claraspital AG, Basel, Switzerland

and more 9 locations

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Phase 1

Terminated

Conditions: Liver Cancer

Interventions: Drug: doxorubicin-eluting beads
Other: placebo
Drug: everolimus

First Posted Date: 2009-11-09

Last Posted Date: 2015-07-07

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 27

Registration Number: NCT01009801

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇨🇭
Kantonsspital - St. Gallen, St. Gallen, Switzerland
🇨🇭
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland

and more 5 locations

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Phase 2

Completed

Conditions: Liver Cancer

Interventions: Drug: everolimus
Drug: sorafenib tosylate

First Posted Date: 2009-10-30

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 106

Registration Number: NCT01005199

Locations: 🇦🇹
Medizinische Universität Wien, Wien, Austria
🇨🇭
Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland
🇨🇭
Saint Claraspital AG, Basel, Switzerland

and more 12 locations

F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer
Palmar-plantar Erythrodysesthesia

First Posted Date: 2009-10-09

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 91

Registration Number: NCT00992706

Locations: 🇨🇭
Universitaetsspital-Basel, Basel, Switzerland
🇨🇭
Spital Buelach, Bulach, Switzerland
🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

and more 12 locations

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

Phase 1

Completed

Conditions: Lymphoma

Interventions: Biological: rituximab
Drug: bendamustine hydrochloride
Drug: lenalidomide

First Posted Date: 2009-10-01

Last Posted Date: 2019-05-15

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 49

Registration Number: NCT00987493

Locations: 🇨🇭
Inselspital Bern, Bern, Switzerland
🇨🇭
Stadtspital Triemli, Zürich, Switzerland
🇨🇭
Kantonsspital Baden, Baden, Switzerland

and more 13 locations

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: everolimus

First Posted Date: 2009-09-14

Last Posted Date: 2019-08-09

Lead Sponsor: Swiss Group for Clinical Cancer Research

Target Recruit Count: 37

Registration Number: NCT00976755

Locations: 🇨🇭
Universitaetsspital-Basel, Basel, Switzerland
🇨🇭
Kantonspital Aarau, Aarau, Switzerland
🇨🇭
Kantonsspital Baden, Baden, Switzerland

and more 9 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy